Modulation of GITR for Cancer Immunotherapy

Overview

Journal Curr Opin Immunol

Publisher Elsevier

Specialty Allergy & Immunology

Date 2012 Jan 17

PMID 22245556

Citations 74

Authors

David A Schaer

Judith T Murphy

Jedd D Wolchok

Affiliations

Soon will be listed here.

Abstract

Modulation of co-inhibitory and co-stimulatory receptors of the immune system has become a promising new approach for immunotherapy of cancer. With the recent FDA approval of CTLA-4 blockade serving as an important proof of principal, many new targets are now being translated into the clinic. Preclinical research has demonstrated that targeting glucocorticoid-induced tumor necrosis factor (TNF) receptor related gene (GITR), a member of TNF receptor superfamily, by agonist antibodies or natural ligand, can serve as an effective anti-tumor therapy. In this review, we will cover this research and the rationale that has led to initiation of two phase 1 clinical trials targeting GITR as a new immunotherapeutic approach for cancer.

Citing Articles

Advances in Cell and Immune Therapies for Melanoma.

Timis T, Buruiana S, Dima D, Nistor M, Muresan X, Cenariu D Biomedicines. 2025; 13(1).

PMID: 39857682 PMC: 11761552. DOI: 10.3390/biomedicines13010098.

Deciphering Regulatory T-Cell Dynamics in Cancer Immunotherapy: Mechanisms, Implications, and Therapeutic Innovations.

Bhattacharya S, Paraskar G, Jha M, Gupta G, Prajapati B ACS Pharmacol Transl Sci. 2024; 7(8):2215-2236.

PMID: 39144553 PMC: 11320738. DOI: 10.1021/acsptsci.4c00156.

Influence of Microbiota on Tumor Immunotherapy.

Yu X, Li W, Li Z, Wu Q, Sun S Int J Biol Sci. 2024; 20(6):2264-2294.

PMID: 38617537 PMC: 11008264. DOI: 10.7150/ijbs.91771.

GITR activation impairs CD8 T cell function in people with HIV on antiretroviral therapy.

Gubser C, Pascoe R, Chang J, Chiu C, Solomon A, Cao R iScience. 2023; 26(11):108165.

PMID: 38026168 PMC: 10660494. DOI: 10.1016/j.isci.2023.108165.

Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4.

Aldahlawi A, Basingab F, Alrahimi J, Zaher K, Pushparaj P, Hassan M Biomed Rep. 2023; 19(2):56.

PMID: 37560313 PMC: 10407466. DOI: 10.3892/br.2023.1638.

References

Cote A, Zhang P, OSullivan J, Jacobs V, Clemis C, Sakaguchi S . Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens. J Immunol. 2010; 186(1):275-83. PMC: 3050990. DOI: 10.4049/jimmunol.1001308. View

Curran M, Kim M, Montalvo W, Al-Shamkhani A, Allison J . Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production. PLoS One. 2011; 6(4):e19499. PMC: 3085474. DOI: 10.1371/journal.pone.0019499. View

Esparza E, Arch R . Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation. J Immunol. 2005; 174(12):7869-74. DOI: 10.4049/jimmunol.174.12.7869. View

Kohrt H, Houot R, Goldstein M, Weiskopf K, Alizadeh A, Brody J . CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. Blood. 2011; 117(8):2423-32. PMC: 3062409. DOI: 10.1182/blood-2010-08-301945. View

Snell L, Lin G, McPherson A, Moraes T, Watts T . T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy. Immunol Rev. 2011; 244(1):197-217. DOI: 10.1111/j.1600-065X.2011.01063.x. View

Piconese S, Valzasina B, Colombo M . OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J Exp Med. 2008; 205(4):825-39. PMC: 2292222. DOI: 10.1084/jem.20071341. View

Ascierto P, Simeone E, Sznol M, Fu Y, Melero I . Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies. Semin Oncol. 2010; 37(5):508-16. DOI: 10.1053/j.seminoncol.2010.09.008. View

Cuzzocrea S, Nocentini G, Di Paola R, Agostini M, Mazzon E, Ronchetti S . Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation. J Immunol. 2006; 177(1):631-41. DOI: 10.4049/jimmunol.177.1.631. View

Snell L, McPherson A, Lin G, Sakaguchi S, Pandolfi P, Riccardi C . CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection. J Immunol. 2010; 185(12):7223-34. DOI: 10.4049/jimmunol.1001912. View

10.

Liu B, Li Z, Mahesh S, Pantanelli S, Hwang F, Siu W . Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis. J Biol Chem. 2008; 283(13):8202-10. PMC: 2276384. DOI: 10.1074/jbc.M708944200. View

11.

Galuppo M, Nocentini G, Mazzon E, Ronchetti S, Esposito E, Riccardi L . GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan. Shock. 2011; 36(3):263-71. DOI: 10.1097/SHK.0b013e3182262c48. View

12.

Zhou Z, Tone Y, Song X, Furuuchi K, Lear J, Waldmann H . Structural basis for ligand-mediated mouse GITR activation. Proc Natl Acad Sci U S A. 2008; 105(2):641-5. PMC: 2206589. DOI: 10.1073/pnas.0711206105. View

13.

Stephens G, McHugh R, Whitters M, Young D, Luxenberg D, Carreno B . Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol. 2004; 173(8):5008-20. DOI: 10.4049/jimmunol.173.8.5008. View

14.

Nocentini G, Riccardi C . GITR: a modulator of immune response and inflammation. Adv Exp Med Biol. 2009; 647:156-73. DOI: 10.1007/978-0-387-89520-8_11. View

15.

Cuzzocrea S, Ronchetti S, Genovese T, Mazzon E, Agostini M, Di Paola R . Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation. FASEB J. 2006; 21(1):117-29. DOI: 10.1096/fj.06-6611com. View

16.

Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T . Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J Exp Med. 2005; 202(7):885-91. PMC: 2213162. DOI: 10.1084/jem.20050940. View

17.

Nishikawa H, Kato T, Hirayama M, Orito Y, Sato E, Harada N . Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling. Cancer Res. 2008; 68(14):5948-54. DOI: 10.1158/0008-5472.CAN-07-5839. View

18.

Croft M . Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol. 2010; 28:57-78. PMC: 2882161. DOI: 10.1146/annurev-immunol-030409-101243. View

19.

Galuppo M, Nocentini G, Mazzon E, Ronchetti S, Esposito E, Riccardi L . The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in mice. Br J Pharmacol. 2010; 162(5):1186-201. PMC: 3051390. DOI: 10.1111/j.1476-5381.2010.01123.x. View

20.

Ronchetti S, Nocentini G, Riccardi C, Pandolfi P . Role of GITR in activation response of T lymphocytes. Blood. 2002; 100(1):350-2. DOI: 10.1182/blood-2001-12-0276. View